510(k) Report

510(k) · Cleared

Cleared

LIAISON Ferritin

K193650510(k) TraditionalCleared Sep 14, 2021624-day reviewClass II21 CFR 866.5340

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

DiaSorin, Inc. · DBF Ferritin, Antigen, Antiserum, Control

Cleared on Sep 14, 2021 as substantially equivalent to K971833 (Boehringer Mannheim Corp., 1997) after a 624-day review. Its family tree reaches back 1 generation to 1997.

Decided
Sep 14, 2021
Review
624 days
Class
Class II
Product code
DBF
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K971833 (1997). No later device cites it as a predicate yet.

K971833 · Elecsys Ferritin · Boehringer Mannheim Corp. · 1997199520002005201020152020
K971833 · Elecsys Ferritin · Boehringer Mannheim Corp. · 19970
  1. Root · 1 generation backK971833 Elecsys FerritinBoehringer Mannheim Corp. · 1997
  2. This deviceK193650 LIAISON FerritinDiaSorin, Inc. · 2021
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K971833Elecsys FerritinBoehringer Mannheim Corp.1997—
0 (this device)K193650LIAISON FerritinDiaSorin, Inc.2021—
FIG. 1 — Lineage of K193650, 1997–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DBF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DBF device

  1. #1 K191562 Yumizen C1200 Ferritin, Yumizen C1200…score -0.7 · 2 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K971833Elecsys Ferritin
Summary page 4
…ification: Class II Product Code: DBF Panel: Subpart F - Immunological Test Systems 6. Predicate Device(s): Roche Elecsys® Ferritin assay previously FDA cleared under (K971833). 7. Device Description: The method for the quantitative determination of ferritin is a sandwich chemiluminescence immunoassay.…
Boehringer Mannheim Corp.1997—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All DBF devices

DBF Ferritin, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · DBF

1in 2021

2009: 12010: 12011: 12012: 12014: 12017: 12020: 12021: 1
2007high 1 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DBF

Too few DBF 510(k)s in any year since 2007 to give a median.

Recalls per year · DBF

3in 2012

2012: 3
2007high 3 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DBF

1in 2025

2012: 12013: 12016: 12017: 22018: 72019: 12020: 12021: 32023: 32024: 12025: 1
2007high 7 (2018) · low 0 (2007)2025

MAUDE reports naming product code DBF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20091—00
20101—00
20111—00
20121—31
20130—01
20141—00
20150—00
20160—01
20171—02
20180—07
20190—01
20201—01
20211—03
20220—00
20230—03
20240—01
20250—01
20260—0—

What is it indicated for?

The DiaSorin LIAISON@ Ferritin assay is a quantitative automated chemiluminescent immunoassay (CLIA) for the in vitro detection of ferritin in human serum, serum separator tubes (SST), or lithium (Li) heparin plasma to aid in the diagnosis of iron deficiency anemia and iron overload.

This assay must be performed on the LIAISON® XL Analyzer.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K193650: LIAISON Ferritin.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K193650

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026